Philipp Schmucker (P Schmucker)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Candida Albicans

Combination Therapy

Metastatic Renal Cell Carcinoma

Top Venues

Clinical & translational immunology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Benedikt Hoeh, Cristina Cano Garcia, Severine Banek, Niklas Klümper, Alexander Cox, Joerg Ellinger, Philipp Schmucker, Oliver Hahn, Angelika Mattigk, Friedemann Zengerling, Philippe Becker, Kati Erdmann, Bjoern Thorben Buerk, Luka Flegar, Johannes Huber, Charis Kalogirou, Philip Zeuschner
Early CRP kinetics to predict long-term efficacy of first-line immune-checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real-world experience applying different CRP kinetics definitions. Clinical & translational immunology 12 (10) (2023)
Niklas Klümper, Philipp Schmucker, Oliver Hahn, Benedikt Höh, Angelika Mattigk, Severine Banek, Joerg Ellinger, Julia Heinzelbecker, Danijel Sikic, Markus Eckstein, Arne Strauß, Friedemann Zengerling, Michael Hudecek, Philip Zeuschner, Charis Kalogirou
C-reactive protein flare-response predicts long-term efficacy to first-line anti-PD-1-based combination therapy in metastatic renal cell carcinoma. Clinical & translational immunology 10 (12) (2021)
C Kalogirou, J Linxweiler, Philipp Schmucker, M T Snaebjornsson, Werner Schmitz, S Wach, M Krebs, E Hartmann, M Puhr, Andreas Müller, M Spahn, A K Seitz, T Frank, H Marouf, Gabriele Büchel, Markus Eckstein, H Kübler, Martin Eilers, M Saar, K Junker, F Röhrig, B Kneitz, Mathias T Rosenfeldt, Almut Schulze
MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer. Nature communications 12 (1) (2021)